Skip to content

Scholar Rock SRRK Business Segments — D&A

Similar metrics at other companies

Rigetti Computing, Inc. logo
RGTISingle Reportable — D&A
$2.62M+43.0%
Clearwater Analytics logo
CWANReportable Segment — D&A
$29.56M+840%
Albertsons Companies logo
ACIReportable Segment — D&A
$474.1M+12.6%
Dollar General logo
DGSingle Reportable — D&A
$260M+7.0%
Twist Bioscience Corporation logo
TWSTReportable Segment — D&A
$6.41M+0.2%
Power Integrations logo
POWISingle Reportable — Depreciation
$6.38M-11.9%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's business segments — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's business segments — D&A?
Scholar Rock (SRRK) reported business segments — D&A of $335K in Q1 2026.
How has Scholar Rock's business segments — D&A changed year-over-year?
Scholar Rock's business segments — D&A decreased by 14.8% year-over-year, from $393K to $335K.
What does business segments — D&A mean?
This represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the business segment. It is a non-cash charge that reflects the consumption of capital investments in laboratory equipment or intellectual property. It is essential for understanding the true cash-generating capability of the segment's asset base.